XML 49 R37.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Organization of the Company (Details Textuals) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2015 USD ($)
Controlled Equity Offering Sales Agreement | Cantor Fitzgerald & Co., ("Cantor") |
Organization [Line Items] |
Maximum amount of offering price for common stock | $ 8,350
Proceeds received through sale of shares | 500
United kingdoms medical research council | Investigational new drug (IND) |
Organization [Line Items] |
Grant award amount | 1,900
Biomedical catalyst of United Kingdom government | Investigational new drug (IND) |
Organization [Line Items] |
Grant award amount | $ 3,500

X
- Definition Represents maximum amount of offering price for common stock. + References No definition available. + Details
Name: | cycc_MaximumAmountOfOfferingPriceForCommonStock
Namespace Prefix: | cycc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | cycc_OrganizationLineItems
Namespace Prefix: | cycc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash received from grantors during the current period related to operating activities. This element represents receipts from a guarantor for the amount of guarantee provided. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromGrantors
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | cycc_AgreementAxis=cycc_ControlledEquityOfferingSalesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TitleOfIndividualAxis=cycc_SalesAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cycc_GrantAwardeeAxis=cycc_UnitedKingdomsMedicalResearchCouncilMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cycc_ProgramAxis=cycc_InvestigationalNewDrugMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cycc_GrantAwardeeAxis=cycc_BiomedicalCatalystOfTheUnitedKingdomGovernmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |